Blockade of the CD93/IGFBP7 interaction by monoclonal antibodies thus promoted vascular maturation and reduced leakage, leading to reduced tumor hypoxia and increased tumor perfusion (Figure 3; Table 3). This evidence concerns the gene CD93 and neoplasm.